Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome
Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technolog...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Yanan Li [verfasserIn] Jinghong Li [verfasserIn] Aijing Leng [verfasserIn] Guixin Zhang [verfasserIn] Jialin Qu [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2024 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Pharmacological Research ; 199(2024), Seite 107006- volume:199 ; year:2024 ; pages:107006- |
|---|
| Links: |
|---|
| DOI / URN: |
10.1016/j.phrs.2023.107006 |
|---|
| Katalog-ID: |
DOAJ100593836 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ100593836 | ||
| 003 | DE-627 | ||
| 005 | 20240414103548.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240414s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phrs.2023.107006 |2 doi | |
| 035 | |a (DE-627)DOAJ100593836 | ||
| 035 | |a (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RM1-950 | |
| 100 | 0 | |a Yanan Li |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. | ||
| 650 | 4 | |a Gallbladder and biliary diseases | |
| 650 | 4 | |a Complication | |
| 650 | 4 | |a Cholecardia syndrome | |
| 650 | 4 | |a Pathogenesis | |
| 650 | 4 | |a Bile acid | |
| 650 | 4 | |a Ursodeoxycholic acid | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 700 | 0 | |a Jinghong Li |e verfasserin |4 aut | |
| 700 | 0 | |a Aijing Leng |e verfasserin |4 aut | |
| 700 | 0 | |a Guixin Zhang |e verfasserin |4 aut | |
| 700 | 0 | |a Jialin Qu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Pharmacological Research |g 199(2024), Seite 107006- |
| 773 | 1 | 8 | |g volume:199 |g year:2024 |g pages:107006- |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2023.107006 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1043661823003626 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1096-1186 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 199 |j 2024 |h 107006- | ||
| author_variant |
y l yl j l jl a l al g z gz j q jq |
|---|---|
| matchkey_str |
yananlijinghongliaijinglengguixinzhangji:2024----:adacmlctosasdyiirdsaeaeiwflnclaiettosahgnssntete |
| hierarchy_sort_str |
2024 |
| callnumber-subject-code |
RM |
| publishDate |
2024 |
| allfields |
10.1016/j.phrs.2023.107006 doi (DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add DE-627 ger DE-627 rakwb eng RM1-950 Yanan Li verfasserin aut Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology Jinghong Li verfasserin aut Aijing Leng verfasserin aut Guixin Zhang verfasserin aut Jialin Qu verfasserin aut In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- https://doi.org/10.1016/j.phrs.2023.107006 kostenfrei https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add kostenfrei http://www.sciencedirect.com/science/article/pii/S1043661823003626 kostenfrei https://doaj.org/toc/1096-1186 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 199 2024 107006- |
| spelling |
10.1016/j.phrs.2023.107006 doi (DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add DE-627 ger DE-627 rakwb eng RM1-950 Yanan Li verfasserin aut Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology Jinghong Li verfasserin aut Aijing Leng verfasserin aut Guixin Zhang verfasserin aut Jialin Qu verfasserin aut In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- https://doi.org/10.1016/j.phrs.2023.107006 kostenfrei https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add kostenfrei http://www.sciencedirect.com/science/article/pii/S1043661823003626 kostenfrei https://doaj.org/toc/1096-1186 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 199 2024 107006- |
| allfields_unstemmed |
10.1016/j.phrs.2023.107006 doi (DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add DE-627 ger DE-627 rakwb eng RM1-950 Yanan Li verfasserin aut Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology Jinghong Li verfasserin aut Aijing Leng verfasserin aut Guixin Zhang verfasserin aut Jialin Qu verfasserin aut In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- https://doi.org/10.1016/j.phrs.2023.107006 kostenfrei https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add kostenfrei http://www.sciencedirect.com/science/article/pii/S1043661823003626 kostenfrei https://doaj.org/toc/1096-1186 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 199 2024 107006- |
| allfieldsGer |
10.1016/j.phrs.2023.107006 doi (DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add DE-627 ger DE-627 rakwb eng RM1-950 Yanan Li verfasserin aut Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology Jinghong Li verfasserin aut Aijing Leng verfasserin aut Guixin Zhang verfasserin aut Jialin Qu verfasserin aut In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- https://doi.org/10.1016/j.phrs.2023.107006 kostenfrei https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add kostenfrei http://www.sciencedirect.com/science/article/pii/S1043661823003626 kostenfrei https://doaj.org/toc/1096-1186 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 199 2024 107006- |
| allfieldsSound |
10.1016/j.phrs.2023.107006 doi (DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add DE-627 ger DE-627 rakwb eng RM1-950 Yanan Li verfasserin aut Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology Jinghong Li verfasserin aut Aijing Leng verfasserin aut Guixin Zhang verfasserin aut Jialin Qu verfasserin aut In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- https://doi.org/10.1016/j.phrs.2023.107006 kostenfrei https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add kostenfrei http://www.sciencedirect.com/science/article/pii/S1043661823003626 kostenfrei https://doaj.org/toc/1096-1186 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 199 2024 107006- |
| language |
English |
| source |
In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- |
| sourceStr |
In Pharmacological Research 199(2024), Seite 107006- volume:199 year:2024 pages:107006- |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid Therapeutics. Pharmacology |
| isfreeaccess_bool |
true |
| container_title |
Pharmacological Research |
| authorswithroles_txt_mv |
Yanan Li @@aut@@ Jinghong Li @@aut@@ Aijing Leng @@aut@@ Guixin Zhang @@aut@@ Jialin Qu @@aut@@ |
| publishDateDaySort_date |
2024-01-01T00:00:00Z |
| id |
DOAJ100593836 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ100593836</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414103548.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2023.107006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ100593836</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yanan Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gallbladder and biliary diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Complication</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cholecardia syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bile acid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ursodeoxycholic acid</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jinghong Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aijing Leng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guixin Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jialin Qu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pharmacological Research</subfield><subfield code="g">199(2024), Seite 107006-</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:199</subfield><subfield code="g">year:2024</subfield><subfield code="g">pages:107006-</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2023.107006</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1043661823003626</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1096-1186</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">199</subfield><subfield code="j">2024</subfield><subfield code="h">107006-</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Yanan Li |
| spellingShingle |
Yanan Li misc RM1-950 misc Gallbladder and biliary diseases misc Complication misc Cholecardia syndrome misc Pathogenesis misc Bile acid misc Ursodeoxycholic acid misc Therapeutics. Pharmacology Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| authorStr |
Yanan Li |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RM1-950 |
| illustrated |
Not Illustrated |
| topic_title |
RM1-950 Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome Gallbladder and biliary diseases Complication Cholecardia syndrome Pathogenesis Bile acid Ursodeoxycholic acid |
| topic |
misc RM1-950 misc Gallbladder and biliary diseases misc Complication misc Cholecardia syndrome misc Pathogenesis misc Bile acid misc Ursodeoxycholic acid misc Therapeutics. Pharmacology |
| topic_unstemmed |
misc RM1-950 misc Gallbladder and biliary diseases misc Complication misc Cholecardia syndrome misc Pathogenesis misc Bile acid misc Ursodeoxycholic acid misc Therapeutics. Pharmacology |
| topic_browse |
misc RM1-950 misc Gallbladder and biliary diseases misc Complication misc Cholecardia syndrome misc Pathogenesis misc Bile acid misc Ursodeoxycholic acid misc Therapeutics. Pharmacology |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Pharmacological Research |
| hierarchy_top_title |
Pharmacological Research |
| isfreeaccess_txt |
true |
| title |
Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| ctrlnum |
(DE-627)DOAJ100593836 (DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add |
| title_full |
Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| author_sort |
Yanan Li |
| journal |
Pharmacological Research |
| journalStr |
Pharmacological Research |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2024 |
| contenttype_str_mv |
txt |
| container_start_page |
107006 |
| author_browse |
Yanan Li Jinghong Li Aijing Leng Guixin Zhang Jialin Qu |
| container_volume |
199 |
| class |
RM1-950 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Yanan Li |
| doi_str_mv |
10.1016/j.phrs.2023.107006 |
| author2-role |
verfasserin |
| title_sort |
cardiac complications caused by biliary diseases: a review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| callnumber |
RM1-950 |
| title_auth |
Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| abstract |
Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. |
| abstractGer |
Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. |
| abstract_unstemmed |
Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| title_short |
Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome |
| url |
https://doi.org/10.1016/j.phrs.2023.107006 https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add http://www.sciencedirect.com/science/article/pii/S1043661823003626 https://doaj.org/toc/1096-1186 |
| remote_bool |
true |
| author2 |
Jinghong Li Aijing Leng Guixin Zhang Jialin Qu |
| author2Str |
Jinghong Li Aijing Leng Guixin Zhang Jialin Qu |
| callnumber-subject |
RM - Therapeutics and Pharmacology |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.phrs.2023.107006 |
| callnumber-a |
RM1-950 |
| up_date |
2024-07-03T15:36:23.046Z |
| _version_ |
1803572722317393920 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ100593836</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414103548.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2023.107006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ100593836</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9045f0f1e2ad4ebd8095c34afebe2add</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yanan Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiac complications caused by biliary diseases: A review of clinical manifestations, pathogenesis and treatment strategies of cholecardia syndrome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gallbladder and biliary diseases (GBDs) are one of the most common digestive diseases. The connections between GBDs and several organs other than the liver have gradually surfaced accompanied by the changes in people's diet structure and the continuous improvement of medical diagnosis technology. Among them, cholecardia syndrome that takes the heart as the important target of GBDs complications has been paid close attention. However, there are still no systematic report about its corresponding clinical manifestations and pathogenesis. This review summarized recent reported types of cholecardia syndrome and found that arrhythmia, myocardial injury, acute coronary syndrome and heart failure are common in the general population. Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/8 and CYP7A1), nerve reflex and autonomic neuropathy were further revealed. Finally, the potential treatment measures and clinical medication represented by ursodeoxycholic acid were summarized to provide assistance for clinical diagnosis and treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gallbladder and biliary diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Complication</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cholecardia syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bile acid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ursodeoxycholic acid</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jinghong Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aijing Leng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guixin Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jialin Qu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pharmacological Research</subfield><subfield code="g">199(2024), Seite 107006-</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:199</subfield><subfield code="g">year:2024</subfield><subfield code="g">pages:107006-</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2023.107006</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9045f0f1e2ad4ebd8095c34afebe2add</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1043661823003626</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1096-1186</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">199</subfield><subfield code="j">2024</subfield><subfield code="h">107006-</subfield></datafield></record></collection>
|
| score |
7.401886 |